Dedicated to Improve Diagnosis of Lung Infections

Lung Infections.

Each year, 2.6 million people die

Our Mission.

Relieving the Burden of Lung Infections

Xheal Technology.

Sampling Site of Infection

Non-Invasive Sampling

No Contamination

Enabling Molecular Diagnostics

Modular Breath Sampler


Lower respiratory infections are a leading cause of death worldwide. Immediate initiation of correct and adequate treatment is of vital importance to ensure a favourable outcome of disease. However, diagnostics methods for lower respiratory infections are limited, especially when it concerns bacterial pathogens.

Currently, sputum culture is the standard. However, culturing takes at least 24 hours and frequently yields inconclusive results due to low sample quality. Faster and more accurate molecular methods are available. Unfortunately, these are most often unable to extract diagnostically relevant information from the biologically complex matrix sputum.

Besides the complexity of sputum, obtaining a sample is an obstacle as ill patients have respiratory impairment. Especially, in case of patients with underlying chronical respiratory disease, e.g. COPD and cystic fibrosis. The latter category of patients is particularly important as they regularly suffer from lower respiratory infections.

Disclaimer; The information contained in this website is for general information purposes only. The information is provided by Inventin and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.​

© 2022 Xheal Diagnostics BV. All rights reserved.